Clinical Study to Evaluate Safety and Efficacy of a Unani Formulation in Anaemia
- Conditions
- Health Condition 1: D539- Nutritional anemia, unspecified
- Registration Number
- CTRI/2023/10/059046
- Lead Sponsor
- ational Research Institute of Unani Medicine for Skin Disorders.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
The following participants will be included in the study:
1 Participants in the age group of 18-60 years of either gender having any of
the following signs and symptoms.
Pallor
Weakness and Fatigue
Dyspnea
Palpitation
Anorexia
Angular Stomatitis and Glossitis
Oedema
Koilonychia (Spoon Shaped Nail)
Dizziness
Fainting
2 Heamoglobin:
Male, >8.0 gm% & <13gm%
Female, >7.0 gm% & < 12.0gm%
The following patients will be excluded from the study:
1 Participants aged <18years and >60years of age.
2 Participants with haemoglobin < 8.0 & >13 gm% in Males where as <7.0
& >12.0 gm% in Female.
3 History of acute blood loss, chronic diseases requiring long term
treatment.
4 Pregnant and lactating women were excluded.
5 Known case of significant Pulmonary/ Cardiovascular/ Hepatorenal
Dysfunction/ Malignancy/ HIV Infection /AIDS etc .
6 Known allergy to herbal drugs.
7 Those who are unwilling to come for regular follow up for the entire
duration of the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Hb(gm/dl) at 12 weeks from base lineTimepoint: 84 days
- Secondary Outcome Measures
Name Time Method 1) Improvement in signs & symptoms <br/ ><br>2) Change in Reticulocyte Count, S.Ferritin level, RBC Count, PCV, MCV, <br/ ><br>MCH,MCHC.Timepoint: 84 days